Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
Add more filters










Publication year range
1.
Carbohydr Res ; 492: 107989, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32276180

ABSTRACT

An O-antigen polysaccharide fraction (Ke-PS) was isolated from Komagataeibacter europaeus NBRC 3261. In addition to chemical analyses, its structure was characterized by 1D and 2D 1H as well as 13C NMR spectroscopy. The polysaccharide is composed of linear disaccharide repeating unit that consists of d-galactose and d-glycero-d-manno-heptose: →7)-α-d,d-Hepp-(1 â†’ 2)-α-d-Galp-(1 â†’ .


Subject(s)
Acetobacteraceae/chemistry , Heptoses/isolation & purification , Polysaccharides/isolation & purification , Carbohydrate Conformation , Heptoses/chemistry , Magnetic Resonance Spectroscopy , Polysaccharides/chemistry
2.
J Biosci Bioeng ; 125(4): 425-431, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29208444

ABSTRACT

Acetobacter pasteurianus is characterized as a fermenting bacterium of kurozu, which is a common traditional Japanese black vinegar. Recently, we separated acid-resistant and low Toll-like receptor 4 (TLR4)-stimulatory lipopolysaccharides (LPS) from A. pasteurianus. We also showed that their lipid A parts possessed a novel sugar backbone that is responsible for the low TLR4-stimulatory and acid-resistant properties of the LPS. Outer membrane vesicles (OMVs) are nano-sized spherical structures secreted from many gram-negative bacteria. OMVs contain LPS and act as immunomodulants such as vaccines. In this study, we investigated OMVs secreted from A. pasteurianus. OMV secretion from A. pasteurianus NBRC 3283 cells was observed after 2 days in culture by transmission electron microscopy imaging. Thus OMVs were separated from the culture supernatants by ultracentrifugation and then purified by OptiPrep density gradient centrifugation. The OMVs contained several proteins including outer membrane proteins, and several sugars as components of LPS. The OMVs weakly stimulated TLR4 in accordance with the activity of A. pasteurianus LPS. Additionally, the TLR2-stimulating activity of the OMVs was significantly potent, indicating the existence of lipoproteins. Furthermore OMV-like spherical particles were observed in kurozu. Some of these particles are probably derived from A. pasteurianus. These data suggest that A. pasteurianus produce OMVs that contain LPS and probably lipoproteins, and can modulate the innate immune system.


Subject(s)
Acetobacter/chemistry , Acetobacter/cytology , Bacterial Outer Membrane Proteins/chemistry , Bacterial Outer Membrane Proteins/immunology , Lipid A/chemistry , Lipid A/immunology , Acetic Acid , Acetobacter/immunology , Animals , Fermentation , Immunity, Innate , Mice , Toll-Like Receptor 4/immunology
3.
Innate Immun ; 23(5): 449-458, 2017 07.
Article in English | MEDLINE | ID: mdl-28606014

ABSTRACT

Bacteroides fragilis is a member of the normal intestinal flora and is involved in host immunostimulation via TLR2. On the bacterial cell surface, glycoconjugates, such as LPS and capsular polysaccharide A (PSA), have been reported to participate in host immunostimulation via TLR2. Previously, we identified a TLR2-stimulating lipoprotein in B. fragilis cells. In this study, we demonstrated that TLR2-stimulating principal molecules in glycoconjugate fractions prepared from B. fragilis are contaminating proteinous molecules, which may also be lipoproteins. The glycoconjugate fractions were prepared by phenol-hot water extraction of B. fragilis wild type and PSA-deficient strains, followed by hydrophobic interaction chromatography. TLR2-stimilating activities of the fractions were not affected by PSA deficiency. By in-gel TLR2-stimulation assay, molecules in high-molecular-mass area, where capsular polysaccharides were migrated, were found not to stimulate TLR2, but those in the range of 15-40 kDa were active. Further, proteinase K could digest the latter molecules and the TLR2-stimulating activities were migrated to the area of below 15 kDa. These results support that proteinous molecules, which are estimated to be lipoproteins, are responsible for almost all TLR2-stimulating activity in the glycoconjugate fractions prepared from B. fragilis.


Subject(s)
Bacterial Outer Membrane Proteins/metabolism , Bacteroides Infections/immunology , Bacteroides fragilis/metabolism , Glycoconjugates/metabolism , Intestines/immunology , Lipoproteins/metabolism , Toll-Like Receptor 2/metabolism , Bacterial Outer Membrane Proteins/genetics , Bacterial Outer Membrane Proteins/immunology , Bacteroides Infections/microbiology , Bacteroides fragilis/genetics , Bacteroides fragilis/immunology , Cell Fractionation , Glycoconjugates/genetics , Humans , Intestines/microbiology , Lipoproteins/genetics , Lipoproteins/immunology , Microorganisms, Genetically-Modified
4.
J Biol Chem ; 291(40): 21184-21194, 2016 Sep 30.
Article in English | MEDLINE | ID: mdl-27539854

ABSTRACT

Acetobacter pasteurianus is an aerobic Gram-negative rod that is used in the fermentation process used to produce the traditional Japanese black rice vinegar kurozu. Previously, we found that a hydrophobic fraction derived from kurozu stimulates Toll-like receptors to produce cytokines. LPSs, particularly LPS from A. pasteurianus, are strong candidates for the immunostimulatory component of kurozu. The LPS of A. pasteurianus remains stable in acidic conditions during the 2 years of the abovementioned fermentation process. Thus, we hypothesized that its stability results from its structure. In this study, we isolated the LPS produced by A. pasteurianus NBRC 3283 bacterial cells and characterized the structure of its lipid A component. The lipid A moiety was obtained by standard weak acid hydrolysis of the LPS. However, the hydrolysis was incomplete because a certain proportion of the LPS contained acid-stable d-glycero-d-talo-oct-2-ulosonic acid (Ko) residues instead of the acid-labile 3-deoxy-d-manno-oct-2-ulosonic acid residues that are normally found in typical LPS. Even so, we obtained a Ko-substituted lipid A with a novel sugar backbone, α-Man(1-4)[α-Ko(2-6)]ß-GlcN3N(1-6)α-GlcN(1-1)α-GlcA. Its reducing end GlcN(1-1)GlcA bond was also found to be quite acid-stable. Six fatty acids were attached to the backbone. Both the whole LPS and the lipid A moiety induced TNF-α production in murine cells via Toll-like receptor 4, although their activity was weaker than those of Escherichia coli LPS and lipid A. These results suggest that the structurally atypical A. pasteurianus lipid A found in this study remains stable and, hence, retains its immunostimulatory activity during acetic acid fermentation.


Subject(s)
Acetobacter/chemistry , Lipid A/chemistry , Acetobacter/immunology , Animals , Carbohydrate Conformation , Cell Line , Hydrogen-Ion Concentration , Hydrolysis , Lipid A/immunology , Mice , Toll-Like Receptor 4/immunology , Tumor Necrosis Factor-alpha/immunology
5.
Vet Immunol Immunopathol ; 165(1-2): 45-53, 2015 May 15.
Article in English | MEDLINE | ID: mdl-25800221

ABSTRACT

Mycoplasma bovis is known as a significant pathogen and cause of large economic losses in beef and dairy calves worldwide. Numerous factors appear to play an important role in the development of disease during infection with M. bovis, e.g., inhibition of immune cell proliferation and induction of lymphocyte apoptosis. However, the mechanisms involved in M. bovis infections have not been explored and remain incompletely understood. We investigated the major cytokine mRNA expression in bovine PBMC stimulated with M. bovis, for comparison, Staphylococcus aureus and Escherichia coli, which are the representative mastitis-causing pathogens. Here we demonstrated that live M. bovis significantly induced tumor necrosis factor alpha (TNF-α), interleukin 12p40 (IL-12), and interferon gamma (IFN-γ) mRNA expression in bovine peripheral blood mononuclear cells (PBMC) at a multiplicity of infection (MOI) of 1000 but not at an MOI of 10 and 100. Live M. bovis at MOIs of 1, 10, and 100 induced significant bovine PBMC proliferative responses compared with unstimulated bovine PBMC. Furthermore, we showed that the cultural supernatant of M. bovis induced a significant increase in TNF-α, IL-6, and IL-10 mRNA expression in bovine PBMC. Our results suggest that M. bovis weakly affects the cellular integrity of bovine PBMC and induces clear proliferative responses and associated cytokine production in them. However, large numbers of live M. bovis are required to induce an immune response in bovine PBMC.


Subject(s)
Cattle Diseases/immunology , Cytokines/physiology , Leukocytes, Mononuclear/physiology , Mycoplasma Infections/veterinary , Mycoplasma bovis/immunology , Animals , Cattle/immunology , Cattle/microbiology , Cattle Diseases/microbiology , Cell Proliferation/physiology , Cytokines/biosynthesis , Enzyme-Linked Immunosorbent Assay , Mycoplasma Infections/immunology , Mycoplasma Infections/microbiology
6.
J Biol Chem ; 287(17): 14023-39, 2012 Apr 20.
Article in English | MEDLINE | ID: mdl-22356913

ABSTRACT

We prepared ß-sheet-rich recombinant full-length prion protein (ß-form PrP) (Jackson, G. S., Hosszu, L. L., Power, A., Hill, A. F., Kenney, J., Saibil, H., Craven, C. J., Waltho, J. P., Clarke, A. R., and Collinge, J. (1999) Science 283, 1935-1937). Using this ß-form PrP and a human single chain Fv-displaying phage library, we have established a human IgG1 antibody specific to ß-form but not α-form PrP, PRB7 IgG. When prion-infected ScN2a cells were cultured with PRB7 IgG, they generated and accumulated PRB7-binding granules in the cytoplasm with time, consequently becoming apoptotic cells bearing very large PRB7-bound aggregates. The SAF32 antibody recognizing the N-terminal octarepeat region of full-length PrP stained distinct granules in these cells as determined by confocal laser microscopy observation. When the accumulation of proteinase K-resistant PrP was examined in prion-infected ScN2a cells cultured in the presence of PRB7 IgG or SAF32, it was strongly inhibited by SAF32 but not at all by PRB7 IgG. Thus, we demonstrated direct evidence of the generation and accumulation of ß-sheet-rich PrP in ScN2a cells de novo. These results suggest first that PRB7-bound PrP is not responsible for the accumulation of ß-form PrP aggregates, which are rather an end product resulting in the triggering of apoptotic cell death, and second that SAF32-bound PrP lacking the PRB7-recognizing ß-form may represent so-called PrP(Sc) with prion propagation activity. PRB7 is the first human antibody specific to ß-form PrP and has become a powerful tool for the characterization of the biochemical nature of prion and its pathology.


Subject(s)
Immunoglobulin G/chemistry , Neuroblastoma/metabolism , Prions/chemistry , Scrapie/metabolism , Animals , Antibodies/chemistry , Circular Dichroism/methods , Genetic Engineering/methods , Humans , Immunohistochemistry/methods , Mice , Microscopy, Atomic Force/methods , Microscopy, Confocal/methods , Peptide Library , Protein Conformation , Protein Folding , Protein Structure, Secondary
7.
J Neuroimmunol ; 236(1-2): 27-38, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21641049

ABSTRACT

In Alzheimer's disease (AD), amyloid-ß (Aß) peptides accumulate in the brain in different forms, including fibrils and oligomers. Recently, we established three distinct conformation-dependent human single-chain Fv (scFv) antibodies, including B6 scFv, which bound to Aß42 fibril but not to soluble-form Aß, inhibiting Aß42 fibril formation. In this study, we determined the mimotopes of these antibodies and found a common mimotope sequence, B6-C15, using the Ph.D.-C7C phage library. The B6-C15 showed weak homology to the C-terminus of Aß42 containing GXXXG dimerization motifs. We synthesized the peptide of B6-C15 fused with biotinylated TAT at the N-terminus (TAT-B6-C15) and characterized its biochemical features on an Aß42-fibrillation reaction in vitro. We demonstrated that, first, TAT-B6-C15 inhibited Aß42 fibril formation; secondly, TAT-B6-C15 bound to prefibril Aß42 oligomers but not to monomers, trimers, tetramers, fibrils, or ultrasonicated fragments; thirdly, TAT-B6-C15 inhibited Aß42-induced cytotoxicity against human SH-SY5Y neuroblastoma cells; and, fourthly, when mice were administered B6-C15-phages dissolved in phosphate-buffered saline, the anti-Aß42 conformer IgG antibody response was induced. These results suggested that the B6-C15 peptide might provide unique opportunities to analyze the Aß42 fibrillation pathway and develop a vaccine vehicle for Alzheimer's disease.


Subject(s)
Amyloid beta-Peptides/antagonists & inhibitors , Amyloid beta-Peptides/immunology , Amyloid/antagonists & inhibitors , Amyloid/immunology , Bacteriophage M13/metabolism , Molecular Mimicry/immunology , Peptide Fragments/physiology , Single-Chain Antibodies/physiology , Amino Acid Sequence , Amyloid/biosynthesis , Amyloid beta-Peptides/metabolism , Animals , Antibody Specificity , Bacteriophage M13/immunology , Cell Line, Tumor , Humans , Immunoglobulin G/biosynthesis , Immunoglobulin G/physiology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Transgenic , Molecular Sequence Data , Peptide Fragments/antagonists & inhibitors , Peptide Fragments/chemical synthesis , Peptide Fragments/immunology , Peptide Fragments/metabolism , Protein Conformation , Single-Chain Antibodies/biosynthesis
8.
Biochem Biophys Res Commun ; 402(1): 19-22, 2010 Nov 05.
Article in English | MEDLINE | ID: mdl-20875795

ABSTRACT

Peptide-displaying bacteriophages induce mimotope-specific antibody responses, suggesting a novel application of phage-display library as bacteriophage vaccine. We examined the antibody response against M13 phage in mice induced by an i.p. administration of M13 phage in phosphate-buffered saline. We showed here that firstly, mice showed strong IgG antibody responses, particularly, in IgG2b, IgG2c, and IgG3 subclasses even in primary responses. Secondly, IgG production in primary response is totally dependent on MyD88 signaling. These responses were almost comparable, but slightly weaker, in TLR2-, TLR4- and TLR7-deficient mice relative to wild-type mice, suggesting that this enhancing effect is not due to plausible LPS contamination. Thirdly, although primary IgG1 response was not detected in wild-type mice, remarkable IgG1 response was induced in TLR9-deficient mice, suggesting that TLR9 pathway functions as regulatory, but not a simple augmenting signaling cascade, and furthermore, the enhanced IgG1 response was not due to adjuvant effect of single-stranded DNA derived from M13 phage. Thus, innate immunity including TLR regulation is crucial for M13 phage vaccine design.


Subject(s)
Bacteriophage M13/immunology , Myeloid Differentiation Factor 88/metabolism , Peptide Library , Toll-Like Receptor 9/metabolism , Vaccines/immunology , Animals , Immunity, Innate , Immunoglobulin G/immunology , Male , Mice , Mice, Inbred C57BL , Mice, Mutant Strains , Myeloid Differentiation Factor 88/genetics , Signal Transduction , Toll-Like Receptor 9/genetics , Vaccines/genetics
10.
J Biochem ; 148(4): 507-15, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20675684

ABSTRACT

The development of new therapeutic targets and strategies to control highly pathogenic avian influenza (HPAI) H5N1 virus infection in humans is urgently needed. Neutralizing recombinant human antibodies would provide important agents for immunotherapy on human H5N1 virus infection and definition of the critical mimotope for vaccine development. In this study, we have characterized an anti-H5-specific scFv clone, 3D1 from the human-scFv-displaying phage library. 3D1 blocked the binding of H5-Fc to MDCK cells in flow cytometry and neutralized H5N1 subtype influenza A viruses in a microneutralization assay. Employing a peptide-displaying phage library, Ph.D-12, the mimotope was determined to be at #128-131 and #204-211 of H5, which are silic acid-binding regions. In consistency with this result, 3D1 binds the recombinant sugar-binding domain (#50G-#272E) produced by a baculovirus vector. The 3D1 antibody employs the germline gene VH1-23. As this antibody is the first human anti-H5 scFv clearly defined on the sugar-binding epitope, it allows us to investigate the influence of amino acid substitutions in this region on the determination of the binding specificity to either sialic acid α2,6-galactose (SA α2,6Gal) or sialic acid α2,3-galactose (SA α2,3Gal) providing new insight for the development of effective H5N1 pandemic vaccines.


Subject(s)
Epitopes , Influenza A Virus, H5N1 Subtype/immunology , Neutralization Tests , Single-Chain Antibodies/immunology , Amino Acid Sequence , Animals , Birds/virology , Cell Line , Epitopes/genetics , Epitopes/immunology , Humans , Influenza A Virus, H5N1 Subtype/pathogenicity , Influenza in Birds/immunology , Influenza in Birds/virology , Influenza, Human/drug therapy , Influenza, Human/immunology , Influenza, Human/virology , Models, Molecular , Molecular Sequence Data , Protein Conformation , Single-Chain Antibodies/genetics , Single-Chain Antibodies/therapeutic use
11.
J Biochem ; 145(6): 799-810, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19270058

ABSTRACT

By a biopanning method using cell sorter, we quickly isolated an antibody phage clone (S1T-A3) specific to human T-lymphotropic virus type 1-carrying T-cell line S1T from a human single chain Fv (scFv) antibody phage library. This scFv antibody bound to HTLV-1-carrying T-cell lines including MT-2, MT-4 and M8166 other than S1T, but not to non-HTLV-1-carrying T-cell lymphomas such as Jurkat and MOLT4 cells. Interestingly, this antibody induced the cell death on S1T cells very quickly (< 30 min). We tried to identify the target molecules by western blotting and mass spectrometric analysis, revealing that the target antigen was HLA class II DR. The cell death was induced only in dimmer form of scFv (diabody) and at 15-fold lower concentration than that of a fusion protein of scFv and human IgG Fc [(scFv)(2)-Fc] or anti HLA-DR mouse whole antibody L243. Thus, S1T-A3 diabody is a small antibody fragment with agonistic activity to induce cell death through HLA-DR. This is the first report elucidating that diabody specific to HLA-DR is effective to induce the cell death in T-cell malignancy especially adult T-cell leukaemic cell line.


Subject(s)
Apoptosis/drug effects , HLA-DR Antigens/immunology , Immunoglobulin Fragments/immunology , Immunoglobulin Fragments/pharmacology , Leukemia, T-Cell/pathology , Peptide Library , Animals , Cell Line , Cell Line, Tumor , Enzyme-Linked Immunosorbent Assay , Flow Cytometry , Humans , Mass Spectrometry , Mice
12.
MAbs ; 1(5): 453-61, 2009.
Article in English | MEDLINE | ID: mdl-20065650

ABSTRACT

A costimulatory signal is required for the full activation of T cells, in addition to the antigen-specific signal via the T cell receptor. The inducible costimulator, ICOS is one of the costimulatory molecules that play an essential role in this process, particularly in the expansion or the development of effector T cells. As blocking of the interaction between ICOS and its ligand, B7RP-1, suppresses the T cell response, it can be applied to the treatment of allograft rejection or autoimmune diseases. Here, we isolated four scFv clones that were specific to human B7RP-1 by biopanning a human antibody phage library. We found that three of these clones inhibited the interaction between ICOS-Fc and B7RP-1-Fc. These inhibitory clones not only recognized B7RP-1 molecules expressed on B cells, as assessed by FACS, but also exhibited inhibitory activity in a proliferation assay of T cells stimulated with anti-CD3 mAb and B7RP-1-Fc. Finally, the suppression effect of the scFv on the allogenic immune response was examined using a mixed lymphocyte reaction assay, which demonstrated a successful inhibition of the allogenic reaction, in spite of the high dose needed for complete inhibition (360 nM).


Subject(s)
Antigens, Differentiation, T-Lymphocyte/drug effects , B7-1 Antigen/immunology , Immunoglobulin Fragments/immunology , Lymphocyte Activation , T-Lymphocytes , Amino Acid Sequence , Animals , Antibody Specificity , B-Lymphocytes/immunology , B-Lymphocytes/metabolism , Flow Cytometry , Humans , Immunoglobulin Fragments/chemistry , Immunoglobulin Fragments/therapeutic use , Inducible T-Cell Co-Stimulator Ligand , Inducible T-Cell Co-Stimulator Protein , Lymphocyte Activation/drug effects , Lymphocyte Activation/immunology , Lymphocyte Culture Test, Mixed , Mice , Molecular Sequence Data , Peptide Library , Surface Plasmon Resonance , T-Lymphocytes/drug effects , T-Lymphocytes/immunology , Transplantation, Homologous/immunology
13.
J Biochem ; 143(4): 475-86, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18174189

ABSTRACT

The pathogenesis of Alzheimer's disease involves conformational changes of A beta. A series of antibodies recognizing a distinct conformation of A beta (snapshot antibody) is useful for both understanding the mechanism of molecular conversion and identifying diagnostic and therapeutic reagents. As A beta with various conformations can be prepared in vitro under varying physicochemical conditions, snapshot antibodies can be isolated by directly binding to target molecules with antibody-displaying phages. We tested the feasibility of this idea. We show a feature of several A beta-reactive antibodies isolated from our human single-chain Fv antibody-phage library and particularly report the characteristics of an scFv clone, B6, selected from the fibrillar A beta 1-42-coated biopanning. B6 bound to fibrillar A beta 1-42 as well as globulomer A beta 1-42 but not to soluble A beta 1-42 or A beta 1-40. B6 inhibited A beta 1-42 fibril formation with 600 nM IC50 in spite of being the monovalent scFv form. Epitope analysis suggested that the binding site might be located at the beta2 sheet of the C-terminus of A beta 1-42. Although it is believed that N-terminus-recognizing antibodies tend to show the capability to inhibit A beta 1-42 fibrillation, B6 is the first human inhibitory antibody recognizing the C-terminus of A beta 1-42.


Subject(s)
Amyloid beta-Peptides/immunology , Antibodies/immunology , Bacteriophages/genetics , Amino Acid Sequence , Amyloid beta-Peptides/chemistry , Antibodies/genetics , Base Sequence , DNA Primers , Electrophoresis, Polyacrylamide Gel , Humans , Molecular Sequence Data , Protein Conformation , Sequence Homology, Amino Acid
14.
J Biochem ; 143(5): 593-601, 2008 May.
Article in English | MEDLINE | ID: mdl-18216066

ABSTRACT

Monocyte chemotactic protein-1 (MCP-1, CC-chemokine ligand 2; CCL2) is involved in the development of various forms of chronic inflammations. Employing the naive human single-chain Fv displaying phage library, we established seven MCP-1-specific scFvs. The MC8 and MC32 clones exhibited blocking activity for the MCP-1-induced chemotaxis of THP-1 cells, in spite of their monovalency. The analysis of V gene usage showed that all clones bore the identical Vh1 gene, IGHV1-24*01, with variable DJ joining sequences, while their Vl usage was relatively varied, suggesting the preferential contribution of the Vh gene. Based on these findings, to minimize the deteriorative influences on the MCP-1 specificity of MC32, we aimed to achieve the affinity maturation of MC32 using MC32 L-chain shuffling library and select MC32 variants. Most MC32 variants increased their affinity by reducing the k(off) value with no influence of the antigen specificity. MC32 variants #22 or #56 showed approximately 15-fold higher affinity than MC32, indicating that the L-chain shuffling library is useful if the Vh is dominantly involved in the determination of the antigen specificity.


Subject(s)
Antibodies, Monoclonal/genetics , Antibodies, Monoclonal/pharmacology , Chemokine CCL2/antagonists & inhibitors , Chemokine CCL2/immunology , Chemotaxis/drug effects , DNA Shuffling , Immunoglobulin kappa-Chains/genetics , Amino Acid Sequence , Antibodies, Monoclonal/immunology , Antibody Affinity , Humans , Immunoglobulin G/immunology , Immunoglobulin Variable Region/chemistry , Immunoglobulin Variable Region/genetics , Immunoglobulin Variable Region/immunology , Immunoglobulin kappa-Chains/chemistry , Immunoglobulin kappa-Chains/immunology , Molecular Sequence Data , Peptide Library , Sequence Homology, Amino Acid , Surface Plasmon Resonance
15.
Prion ; 2(3): 118-22, 2008.
Article in English | MEDLINE | ID: mdl-19158507

ABSTRACT

The structure and the dissociation reaction of oligomers Pr(Poligo) from reduced human prion huPrP(C)(23-231) have been studied by (1)H-NMR and tryptophan fluorescence spectroscopy at varying pressure, along with circular dichroism and atomic force microscopy. The 1H-NMR and fluorescence spectral feature of the oligomer is consistent with the notion that the N-terminal residues including all seven Trp residues, are free and mobile, while residues 105 approximately 210, comprising the AGAAAAGA motif and S1-Loop-HelixA-Loop-S2-Loop-HelixC, are engaged in intra- and/ or inter-molecular interactions. By increasing pressure to 200 MPa, the oligomers tend to dissociate into monomers which may be identified with PrP(C*), a rare metastable form of PrP(C) stabilized at high pressure (Kachel et al., BMC Struct Biol 6:16). The results strongly suggest that the oligomeric form PrP(oligo) is in dynamic equilibrium with the monomeric forms via PrP(C*), namely huPrP(C)[left arrow over right arrow]huPrP(C*)[left arrow over right arrow]huPrP(oligo).


Subject(s)
PrPC Proteins/chemistry , Circular Dichroism , Fluorescence , Humans , Magnetic Resonance Spectroscopy , Microscopy, Atomic Force , Oxidation-Reduction , PrPC Proteins/ultrastructure , Pressure , Protein Structure, Quaternary , Temperature , Tryptophan
16.
Biol Pharm Bull ; 30(8): 1361-4, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17666785

ABSTRACT

Biopanning of a phage library using a Western blotting membrane is difficult because of high background binding. We propose a reliable biopanning method, namely, immunogel-biopanning, which is performed using immunoplates coated with a molecular species fractionated from a crude sample by native polyacrylamide gel electrophoresis (PAGE). The efficacy of this method was determined in model experiments using a human interleukin-18 (IL-18)-specific single chain Fv (scFv) phage clone.


Subject(s)
Antibodies/chemistry , Bacteriophages/chemistry , Electrophoresis, Polyacrylamide Gel/methods , Immunochemistry/methods , Interleukin-18/analysis , Antibody Specificity , Cloning, Molecular , Colony-Forming Units Assay , DNA/analysis , DNA/genetics , Enzyme-Linked Immunosorbent Assay , Humans , Interleukin-18/biosynthesis , Interleukin-18 Receptor alpha Subunit/metabolism , Protein Conformation , Sequence Analysis, DNA
17.
J Biochem ; 138(4): 433-42, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16272137

ABSTRACT

IL-18 is an important regulator in both innate and acquired immune responses. The aberrant expression of IL-18 is associated with severe inflammatory conditions, such as autoimmune diseases and allergies. Thus, human antibodies with inhibitory activity on IL-18 signaling may be useful for therapeutic applications. We report here the first establishment of an antagonistic anti-IL-18 complete human antibody, h18-108, employing a human single chain antibody (scFv)-displaying phage library. The h18-108 scFv inhibited the IFN-gamma production of a human myelomonocytic cell line, KG-1. Flow cytometry analysis showed that h18-108 blocked the binding of IL-18 to KG-1 cells. Epitope mapping analysis using two kinds of random peptide-displaying phage libraries and an IL-18 alanine mutant (D98A) demonstrated that the h18-108 scFv binds to the site 3 of IL-18, which is suggested to be an association site with the IL-18 receptor beta. The complete human Fab and IgG forms of h18-108 have been successfully constructed to attain increases in both binding affinity and inhibitory activity.


Subject(s)
Antibodies, Monoclonal/pharmacology , Interleukin-18/immunology , Amino Acid Sequence , Antibodies, Monoclonal/chemistry , Antibodies, Monoclonal/therapeutic use , Antibody Affinity , Antibody Specificity , Binding Sites, Antibody , Enzyme-Linked Immunosorbent Assay , Epitope Mapping , Humans , Immunoglobulin Fab Fragments/chemistry , Immunoglobulin Fab Fragments/metabolism , Immunoglobulin G/chemistry , Immunoglobulin G/metabolism , Immunoglobulin Variable Region/chemistry , Immunologic Techniques , Interferon-gamma/biosynthesis , Interleukin-18/antagonists & inhibitors , Interleukin-18/metabolism , Interleukin-18 Receptor alpha Subunit , Molecular Sequence Data , Peptide Library , Receptors, Interleukin/antagonists & inhibitors , Receptors, Interleukin/metabolism , Receptors, Interleukin-18 , Signal Transduction/drug effects
18.
J Biochem ; 133(1): 43-9, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12761197

ABSTRACT

The alpha-chain of Fc epsilon RI (Fc epsilon RIalpha) plays a critical role in the binding of IgE to Fc epsilon RI. A fully human antibody interfering with this interaction may be useful for the prevention of IgE-mediated allergic diseases. Here, we describe the successful isolation of a human single-chain Fv antibody specific to human Fc epsilon RIalpha using human antibody phage display libraries. Using the non-immune phage antibody libraries constructed from peripheral blood lymphocyte cDNA from 20 healthy subjects, we isolated three phage clones (designated as FcR epsilon 27, FcR epsilon 51, and FcR epsilon 70) through two rounds of biopanning selection. The purified soluble scFv, FcR epsilon 51, inhibited the binding of IgE to recombinant Fc epsilon RIalpha, although both FcR epsilon 27 and FcR epsilon 70 showed fine binding specificity to Fc epsilon RIalpha. Since FcR epsilon 51 was determined to be a monomer by HPLC, BIAcore analysis was performed. The dissociation constant of FcR epsilon 51 to Fc epsilon RIalpha was estimated to be 20 nM, i.e., fortyfold lower than that of IgE binding to Fc epsilon RIalpha (K(d) = 0.5 nM). With these characteristics, FcR epsilon 51 exhibited inhibitory activity on the release of histamine from passively sensitized human peripheral blood mononuclear cells.


Subject(s)
Immunoglobulin E/metabolism , Immunoglobulin Variable Region/pharmacology , Receptors, IgE/antagonists & inhibitors , Amino Acid Sequence , Blotting, Western , Cells, Cultured , Histamine Release/drug effects , Humans , Hypersensitivity/therapy , Immunoglobulin E/immunology , Immunoglobulin Fc Fragments/chemistry , Immunoglobulin Variable Region/chemistry , Immunoglobulin Variable Region/genetics , Immunoglobulin Variable Region/immunology , Leukocytes, Mononuclear/immunology , Molecular Sequence Data , Peptide Library , Receptors, IgE/immunology , Receptors, IgE/metabolism , Sequence Alignment , Single-Chain Antibodies
SELECTION OF CITATIONS
SEARCH DETAIL
...